Welcome to Startup Daily’s new regular column on who’s new in the startup zoo – people moving about.
This week we have new CEOs. directors and VC partners.
If you’d like share details on key staff, board or advisor appointments, let us know on news[at]startupdaily.net.
Oli appoints US medtech exec Colby Holtshouse to board
Maternal health technology startup Oli has appointed US-based medtech executive Colby Holtshouse to its board as it prepares submissions to Australian and US regulators for its wireless maternal and fetal monitor.
Holtshouse was previously chief operating officer at Alydia Health before its acquisition by Organon, where she became global medtech commercial lead and led commercialisation of the JADA System to treat postpartum haemorrhage. She is now CEO and president of May Health, which develops technology to address ovarian conditions and related infertility.
Led by CEO Tara Croft, Oli is developing monitoring technology designed to predict complications such as postpartum haemorrhage before they occur. The startup has raised $25 million and recently completed its final pivotal trial ahead of regulatory submissions, enrolling 1,000 mothers across seven Australian and US hospitals.
Get the best of Startup Daily straight to your inbox
Want to know the latest in startup news? Subscribe to our daily news and analysis coverage on what’s happening to ANZ startups, investors and the broader ecosystem. And best of all, it’s FREE!
By continuing, you agree to our Terms & Conditions and Privacy Policy .
Elaine Stead promoted to Main Sequence partner
Deep tech venture capital firm Main Sequence has promoted Dr Elaine Stead from principal to partner 2.5 years after she joined the CSIRO-backed fund.
Stead has a PhD in biochemistry specialising in stem cell biology, experience founding a startup and more than a decade in venture capital. She has led the firm’s healthcare investment strategy, backing companies including Kinoxis Therapeutics, cancer treatment developer Currus Biologics and non-invasive glucose monitoring startup Xoma Labs.
Main Sequence backs businesses commercialising scientific research. It also runs Atmosphere, a pre-seed program supporting Australian scientists.
Aurora Labs makes Andrew Garth CEO , Rebekah Letheby moves to COO
Aurora Labs (A3D:ASX), the WA additive manufacturer developing metal 3D printing technology and propulsion systems for defence drones, is changing its C-suite guard, with former CEO Rebekah Letheby moving to the chief operating officer role, replaced by Andrew Garth.
Garth was previously Aurora’s executive director for strategy and partnerships. An aeronautical engineer with more than 20 years’ experience, he worked on Joint Strike Fighter and Airbus programs at GKN Aerospace and held roles with government defence industry organisations. Letheby will focus on technical delivery and defence customer relationships, while Garth leads strategy and market engagement.
Roman Reyhani heads up NZ’s advanced technology institute
The New Zealand Institute for Advanced Technology has named Roman Reyhani as its new CEO, taking on the role on October 19. Raised in Auckland, Reyhani returned to New Zealand last year after more than two decades overseas in law, technology and venture development.
Reyhani spent six years at BCG Digital Ventures and subsequently BCG X, developing and commercialising technology businesses across areas including energy, advanced manufacturing, automotive and financial services. NZIAT connects researchers, businesses and investors to commercialise research, with a focus on advanced materials, AI and quantum technologies.
Michael Datta joins Powerhouse Venture Partners
Noosa Partners founding director Michael Datta has joined Powerhouse Venture Partners as strategic growth partner, alongside a collaboration between the two businesses.
Datta brings 30 years’ experience founding, building and exiting businesses, with connections across Australian and US defence and medical industries.
The new division of ASX-listed Powerhouse Ventures will work with emerging technology companies on commercialisation, capital strategy and international expansion.
The Noosa partnership adds commercial and market-entry support in the US and Europe.
Simon has been editor of Startup Daily since 2019. He hosted the Startup Daily show on streaming service ausbiz.com.au from 2020 to 2023, and now, the weekly podcast Startup 360. He was previously associate editor of Business Insider Australia, a national restaurant critic, editor of The Good Food Guide, and newspaper proprietor during a 30-plus-years career in journalism and publishing. He’s also an investor in early stage startups.
Recommended for you
Birth monitoring startup Oli kicks with $6.5 million in round 3 Series A
Simon Thomsen May 26, 2026
Cheque in: 3 startups ended May by raising $15.5 million
Tegan Jones Simon Thomsen + 1 MORE May 29, 2026
_SOUTHSTART gives a first peek at its 2025 program lineup
Startup Daily Jan 21, 2025


